During the past decade, AMC Research, LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AMC Research, LLC" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Alzheimer's Disease Dementia" (1 trials), "Dementia of Alzheimer Type" (1 trials) and "Mild Cognitive Impairment Due to Alzheimer's Disease" (1 trials). Many other conditions were trialed in "AMC Research, LLC" in a lesser frequency.

Most popular intervention types in "AMC Research, LLC" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ATH-1017" (2 trials), "Aducanumab" (2 trials), "BIIB080" (1 trials) and "BIIB080-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "AMC Research, LLC" are 7 trials for "All" genders.

Currently, there are NaN active trials in "AMC Research, LLC". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in AMC Research, LLC, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AMC Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".